Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972605 · ClinicalTrials.gov registry record
Delphinus SoftVue™ ROC Reader Study
A clinical trial of Breast Cancer Detection and Dense Breast Parenchyma, sponsored by Delphinus Medical Technologies.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT03972605 is a study of Breast Cancer Detection and Dense Breast Parenchyma that has completed, run by Delphinus Medical Technologies. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03972605, a study of Breast Cancer Detection and Dense Breast Parenchyma, has completed, sponsored by Delphinus Medical Technologies.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this multi-reader, multi-case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This reader study will include approximately 32 radiologist readers and a sample of approximately 200 breast screening cases to be selected from the library of images collected under Delphinus Protocol #DMT-2015.001 (NCT03257839) Arm 1 Phases B, C, and D. The reader study image case set will be enriched with cancer cases.
Conditions Studied
Interventions
- DEVICE Reading of Automated Breast Ultrasound in conjunction with Screening Mammography
Study Locations (1)
Michigan
- Cobo Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-06-08 |
| Est. Completion | 2019-07-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03972605
The ClinicalTrials.gov registry entry for NCT03972605 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Delphinus Medical Technologies, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer Detection appearing as the primary indexed condition, and to 1 intervention - of which Reading of Automated Breast Ultrasound in conjunction with Screening Mammography is the first listed.
NCT03972605 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03972605 about?
NCT03972605 is a clinical study titled "Delphinus SoftVue™ ROC Reader Study". The purpose of this multi-reader, multi-case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This reader study will include approxi...
What is the current status of trial NCT03972605?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2019-06-08. Estimated completion is 2019-07-02.
What conditions does trial NCT03972605 study?
This clinical trial studies the following conditions: Breast Cancer Detection, Dense Breast Parenchyma, Benign Breast Findings, Normal Breast Screening, Abnormal Breast Screening.
What interventions are being tested in trial NCT03972605?
The interventions under investigation include: Reading of Automated Breast Ultrasound in conjunction with Screening Mammography (DEVICE).
Who is sponsoring clinical trial NCT03972605?
This trial is sponsored by Delphinus Medical Technologies, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03972605 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Detection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.